Insulet | PODD - PE Price to Earnings


Insulet reported 21.28 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Abbott 34.85 10.99 Sep/2026
Align Technology 17.17 4.64 Sep/2026
AtriCure 185.48 56.48 Sep/2026
Baxter International 20.35 131.6 Sep/2026
Becton, Dickinson and Co. 20.8 4.77 Sep/2026
Boston Scientific 15.51 2.35 Sep/2026
Cardinal Health 20.54 5.62 Sep/2026
Cooper Companies 24.8 1.53 Jun/2026
Dexcom 31.31 6.7 Sep/2026
Edwards Lifesciences 51.38 20.61 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Globus Medical 20.95 1.36 Sep/2026
ICU Medical 67.77 37.33 Sep/2026
Inogen 69.33 30.67 Sep/2021
Insulet 21.28 8.38 Sep/2026
Integra LifeSciences 8.02 2.26 Sep/2026
J&J 25.86 3.57 Sep/2026
Medtronic 18.15 1.51 Jun/2026
Merit Medical Systems 31.16 1.27 Sep/2026
Roche Holding 16.48 0.39 Jun/2026
Solventum Corp 46.08 2.4 Sep/2026
Stryker 80.48 53.02 Sep/2026
Tandem Diabetes Care 681.05 189.32 Mar/2022
Teleflex 89.77 40.52 Jun/2026
West Pharmaceutical Services 40.64 1.99 Sep/2026
Zimmer Biomet Holdings 21.56 4.23 Sep/2026